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Background: The aim of this study was to examine the effect of radiofrequency ablation (RFA) of ven-
tricular arrhythmias from right ventricular outﬂow tract (RVOT) during long-term follow-up.
Methods: A follow-up analysis was conducted using an in-house questionnaire, as well as a qualitative
assessment of the patients' medical records. The study population of 34 patients had a previous diagnosis
of idiopathic VT or frequent PVCs from the RVOT, and received RFA treatment between 2002 and 2005.
Results: The main symptoms prior to RFA were palpitations (82.4%) and dizziness (76.5%). A reduction in
symptoms followingRFAwas reportedby91.2%ofpatients (p<0.001). Furthermore, therewasa reduceduse
of antiarrhythmicmedication afterRFA (p<0.001).General healthperceptionclassiﬁedona scaleof 1 (poor)
to 4 (excellent), improved from median class 1 to 3 (p < 0.001) during long-term follow-up. The ﬁtness to
work increased frommedianclass3 to class5 (1¼ incapacitated, 5¼ full timeemployment, p¼0.038),while
the rate of patients in full time employment increased from 26.5% to 55.9% after RFA (p ¼ 0.02).
Conclusions: A reduction of symptoms and use of antiarrhythmic medication, as well as an improvement
in the general health perception and ﬁtness to work after RFA of idiopathic ventricular arrhythmias can
be demonstrated at ten-year follow-up.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Idiopathic ventricular tachycardia (VT) or frequent premature
ventricular contractions (PVCs) from the right ventricular outﬂow
tract (RVOT) occur in patients without structural heart disease.
Although the patients with these arrhythmias can be highly
symptomatic, these arrhythmias tend to follow a benign clinical
course [1,2]. The aim of the treatment is therefore to reduce
symptoms and improve quality of life [3]. Radiofrequency ablation
(RFA) is a safe and effective treatment to reduce symptoms and
eliminate VT and PVCs [4]. As many of the patients are young and
healthy individuals, a single intervention with RFA may bew-up; PVCs, premature ven-
OT, right ventricular outﬂow
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ociety. Production and hosting bypreferred over the lifelong use of antiarrhythmic drugs. In patients
with frequent PVCs from RVOT it may also improve cardiac function
[5]. Some patients experience recurrent tachycardia, which po-
tentiates the development of cardiomyopathy and heart failure.
These patients could also beneﬁt from RFA treatment [6,7]. RFA is
generally more successful in patients with VT and PVCs originating
from the RVOT than from other heart structures [8]. A high success
rate of RFA treatment is well documented at mid- and short-term
follow-up (FU), but knowledge about long-term FU is still limited
[9]. The aim of this retrospective study is to examine the effect of
the RFA treatment at long-term FU, measured by the patient's
symptomatic complaints, use of antiarrhythmic medication, gen-
eral health perception and their reported ﬁtness to work.2. Materials and methods
2.1. Study population
The study population consisted of patients recruited from a local
quality register at our hospital. All patients suffered from idiopathicElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Reported symptoms prior to RFA.
Reported symptoms prior to RFA Percentage (%)
Palpitations 82.4
Diaphoresis 35.3
Dyspnoea 47.1
Dizziness 76.5
Syncope 38.2
Chest pain 35.3
Other 41.2
No reported symptoms 2.9
RFA, radiofrequency ablation.
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the time period from 2002 to 2005. The patients had been exam-
ined by echocardiography, magnetic resonance images/computer
tomography and/or coronary angiography prior to the procedure to
rule out structural heart disease, as such patients were excluded
from the study. The study was approved by the regional ethical
committee and informed consent was obtained from all patients.
2.2. Electrophysiological study and ablation procedure
All patients were fasting and under mild sedation to avoid po-
tential suppression of clinical VT or PVCs. If spontaneous VTor PVCs
was not observed, they were induced by pace and/or isoproterenol
infusion. This was registered on a 12-lead surface electrocardiog-
raphy (ECG) and used as template for pace mapping (BARD, elec-
trophysiology, Lowell, USA). Activation mapping was used with
(n ¼ 18) or without (n ¼ 16) a 3-dimensional mapping system
(EnSite array, Endocardial Solutions, SJ Medical, St. Paul, USA) in
addition to pace mapping in all procedure. Radiofrequency ablation
was performed using a 4 mm-cool tip ablation catheter (Biosense
Webster Cordis, Diamond Bar, USA) in all procedures except one,
where a 4 mm non-irrigated tip catheter was used. The ablation
was performed at the best achievable pace map and/or the site of
earliest local activation. After ablation, all patients were kept under
observation for 30 min. The elimination of spontaneous clinical VT
or PVCs via isoproterenol administration and non-inducibility of
the clinical ventricular arrhythmias was the procedural endpoint. A
pericardial effusion was ruled out in all patients 24 h post
intervention.
2.3. Follow-up
The patients were examined using an in-house questionnaire
comprising a self-evaluation score. The patients were asked to
report on all symptoms commonly experienced from these ar-
rhythmias. They also rated their overall general health perception
as a consequence of their arrhythmia on a scale from 1 (poor) to 4
(excellent), as well as their ﬁtness to work on a scale from 1
(incapacitated) to 5 (full time employment) prior to RFA, immedi-
ately after treatment with RFA and at long-term FU. The antiar-
rhythmic drugs were listed in the questionnaire. All patients were
contacted by telephone and given sufﬁcient information to avoid
any misinterpretation of the self-evaluation scores. A qualitative
assessment of the patients' medical records was also performed. A
12-lead ECG recording was performed in patients who were able to
sustain an outpatient examination, either in the ambulatory clinic
at our hospital or at their local hospital. All follow-ups and ECG
were conducted at long-term FU, 10 years after the RFA procedure.
2.4. Statistical analyses
Statistical analyses were performed using SPSS version 22 (SPSS,
Chicago, IL, USA). Discrete variables were reported as percentages
and continuous variables as mean ± SD, and compared using the
paired Student's t-test and nonparametric Wilcoxon Rank test.
Median and range values were also presented. P values < 0.05 were
considered statistically signiﬁcant.
3. Results
Of the 36 patients originally included in the study, one patient
pulled out of the study whilst one patient died during the RFA
procedure, leaving 34 patients eligible for analysis. 11 participants
suffered from idiopathic VT whilst 23 patients experienced
frequent PVCs from the RVOT. The ﬁnal study population thatparticipated in a long-term-follow-up program comprised 18 fe-
males and 16 males with an average age of 56.3 ± 12.6 (range
32e81) years.
3.1. Electrophysiological study and ablation procedure
The RFA procedure was performed using activation mapping,
with (n ¼ 18) or with out additional 3D mapping system (n ¼ 16),
and pacemapping. X-ray duration in the 3D group was signiﬁcantly
higher compared to the pace mapping group (56.4 ± 30.5 versus
24.3 ± 18.6 min, p < 0.05). Prior to the ablation procedure, VT was
induced in 11 patients, whilst PVCs occurred spontaneously or was
induced in the remaining 23 patients. VT or PVCs could not be
induced in 30 patients after the ablation procedure, while four
patients had considerably fewer episodes of PVCs, resulting in an
immediate success rate of 88.2% from the RFA treatment. One of the
initially unsuccessfully treated patients underwent further suc-
cessful ablation after 2005, resulting in a long-term success rate of
91.2% overall. During long-term follow-up three patients who had
an initial successful RFA had recurrence of arrhythmia (10%). Two of
those patients underwent further successful ablation after 2005,
but the last patient chose treatment with antiarrhythymic medi-
cation instead of a new RFA.
3.2. Follow-up
The time from the RFA procedure to follow-up had a mean of
10.9 years and a range of 9e12 years. The response rate was 97%.
3.3. Twelve-lead electrocardiogram analysis
A 12-lead ECG was performed on 17 patients (50%). ECG read-
ings from 12 patients (70.6%) showed a normal ECG without any
PVCs. Three patients (17.6%) displayed continuous PVCs on ECG
post intervention. One patient (5.9%) presented with Qwaves in the
precordial leads and one patient (5.9%) developed asymptomatic
ﬁrst-degree atrioventricular block.
3.4. Effect of RFA on symptoms and antiarrhythmic medications
The main symptoms prior to RFA treatment were palpitations
(82.4%) and dizziness (76.5%). Reported symptoms are listed in
Table 1. A statistically signiﬁcant reduction in symptoms following
RFA treatment was reported by 91.2% of patients (p < 0.001) at
long-term follow-up. Out of these patients, 55.9% reported no
clinical symptoms and 35.3% experienced a reduction in their
symptomatic burden. Antiarrhythmic drugs such as sotalol, beta-
blockers, potassium channel blockers and amiodarone were used
in 26 patients prior to RFA. Ten patients used antiarrhythmic
medication after RFA at long-term FU, and a signiﬁcant reduction of
antiarrhythmic medication could be demonstrated (p < 0.001). The
Fig. 2. Percentage of patients in full time employment prior to RFA and after RFA at
long-term follow-up. RFA, radiofrequency ablation.
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1.29 ± 0.46 after RFA at long-term FU (p < 0.001).
3.5. Effect of RFA on general health perception and ﬁtness to work
General health perception improved signiﬁcantly from median
class 1 to 3 (p < 0.001) immediately after RFA and remained stable
at long-term follow-up (Fig. 1). The mean general health perception
was 1.7 ± 1.1 prior to RFA, 2.95 ± 0.95 immediately after RFA and
3.18 ± 0.80 at long-term follow-up. There was no statistically sig-
niﬁcant (p ¼ 0.19) improvement in general health perception at
long-term follow-up compared to short-term follow-up. The ﬁtness
to work showed a statistically signiﬁcant increase (p ¼ 0.038) from
median class 3 prior to RFA to class 5 at long-term FU. The mean
ﬁtness to work was 2.65 ± 1.23 prior to RFA, and 3.50 ± 1.86 at long
term FU. Fig. 2 presents percentages of patients in full time
employment.
4. Discussion
This study documents the long-term follow-up (>10 years) after
RFA treatment on patients with idiopathic ventricular arrhythmias
originating from the RVOT. The purpose of this study was to
examine patient's clinical outcome. This as extensive research
focusing on rhythm surveillance and ECG morphology previously
had been documented, and the clinical aim of RFA treatment was to
eliminate symptoms and improve quality of life [10,11]. Our major
ﬁndings included both a reduction of symptoms and use of anti-
arrhythmic medication. Furthermore, patients reported an
improvement in both their general health perception and ﬁtness to
work.
Our study showed an immediate success rate of 88.2% from RFA
treatment. Reasons for unsuccessful RFA treatment were either that
the arrhythmia foci were anatomically inaccessible, or that the ar-
rhythmias were non-inducible prior to the procedure. Three of the
patients with unsuccessful RFA undertook a new RFA in the time
period from 2002 to 2005 or later. The second attempt proved
successful for all three patients. The last patient with an unsuc-
cessful ablation chose antiarrhythmic drug therapy instead of a
new RFA, and reported no symptomatic burden at ten years follow
up. The overall recurrence rate in the study population was 10%. A
similar recurrence rate was also documented by Buxton et al. [12].
Palpitations and dizziness were the most commonly reported
symptoms. Dizziness is a common medical symptom that canFig. 1. Percentage reported general health perception of total study group prior to RFA, a
statistically signiﬁcant improvement in health perception, at 5%, when comparing prior tosigniﬁcantly affect the patient's daily activities [13] and can be
caused by factors other than cardiac arrhythmias [14]. It is thus
difﬁcult to determine whether the dizziness was caused by VT or
PVCs, and not from other common causes. However, our study
showed that 91.2% of patients reported a statistically signiﬁcant
improvement in ailments related to heart rhythm disorder imme-
diately after RFA treatment and during long-term FU, supporting
the suspicion that ailments actually was related to the heart rhythm
disorder. Of these patients, 35.3% experienced a decrease in their
symptomatic burden. Although they still suffered from aliments
related to their VT or PVC after RFA treatment, it did not affect their
ﬁtness to work and general health perception during long-term FU.
Our study showed a signiﬁcant reduction in the use of antiar-
rhythmic medication after RFA at long-term FU. However, ten pa-
tients were still using antiarrhythmic medication at long-term FU.
This is not unexpected, as 35.3% of patients experienced a decrease
in symptomatic burden only, and 8.8% of patients reported no
improvement in aliments overall. For patients who used antiar-
rhythmic medicine before and not after RFA, and got an improve-
ment in aliment after RFA we can assume that the improvement is
due to RFA. For patients using antiarrhythmic medication before
and after RFA, but still got an improvement in aliments after RFA,
we cannot rule out that the improvement of the ailments are
partially placebo effect. Use of antiarrhythmicmedication is still the
preferred ﬁrst choice of treatment of idiopathic VT or PVC [15,16].fter RFA and during long-term follow-up. RFA, radiofrequency ablation. *Indicates a
RFA and long-term follow-up.
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from the lifelong need of antiarrhythmic medication, with their
potential side effects, as well as the risk of polypharmacy. The po-
tential medical and ﬁnancial implications could make RFA the
preferred treatment among the patients.
General health perception improved signiﬁcantly following RFA
treatment. General health, symptoms and employability are all
interlinked factors affecting a patient's quality of life. Although
there was no statistically signiﬁcant improvement in general health
perception at long-term follow-up compared to immediately after
RFA treatment, an improving trend was observed. Approximately
21% of the patients reported that their general health was very good
or good prior to RFA. This perception was due to limited or no
symptomatic burden, which was consistent with previous studies
[1]. They documented that some patients with idiopathic VT or
PVCs are asymptomatic. The percentage of patients in full time
employment more than doubled at long-term follow up to 55.9%
compared to 26.5% prior to RFA, demonstrating the medical and
social beneﬁts of RFA. Whilst one patient (2.9%) was incapacitated
due to arrhythmia, the remaining 41.2% of the patients are not in
full time employment due to retirement, incapacitation or sick
leave for other reasons than the heart rhythm disorder. This sup-
ports our ﬁnding that RFA positively affects ﬁtness to work during
long-term FU.
None of the patients had clinically developed heart failure,
malignant clinical arrhythmia or sudden arrhythmogenic death at
long-term follow-up. However, we have no data available con-
cerning the echocardiographic ﬁndings in our patient population.
The average x-ray duration in the 3Dmapping group was higher
compared to the pace mapping group. This might be explained by
the use of the 3D system in an early stage of development whereas
pace mapping has been a part of clinical routine for several years.
The results of this study can be inﬂuenced by the population size
and the number of patients lost to follow-up. The small sample size
may have reduced the power of the statistical analysis resulting in
non-signiﬁcant results. Furthermore, if the patients lost to follow
up had answered signiﬁcantly different from the average popula-
tion it would affect the results. According to Isaac and Michael [17]
a response rate of at least 80% is necessary to obtain good estimates.
Of all patients who were given the questionnaire only one patient
chose not to participate in the study. The response rate in the pa-
tient population was thus 97%, and the results are unlikely to have
been skewed by this absence. This is evident as previous studies on
RFA treatment of VT or PVC (including non-idiopathic arrhythmia)
use similar sample sizes [5,18e20].
4.1. Limitations
This is a descriptive study of a relatively small number of pa-
tients without a control group. As there was no validated template
questionnaire available for the main purpose of this study, an in-
house questionnaire with disease speciﬁc questions was consid-
ered the most appropriate approach to identify patients' overall
burden of arrhythmia. To ensure that the answers were reliable an
additional follow-up was completed via telephone to avoid any
misunderstanding about the questionnaire. As it could be chal-
lenging to accurately recall details from events occurring ten years
previously, the patient's medical records were used as supporting
documentation, allowing for possible recall bias. No long-term
rhythm surveillance (Holter) was obtained, as the patients were
geographical spread across the country. However, a 12-lead ECG
can reveal some PVCs. The procedural records do not include pro-
cedure time and radiofrequency time that might be of interest.5. Conclusions
In conclusion, a reduction in the use of antiarrhythmic medi-
cation and symptoms, as well as an improvement in general health
perception and ﬁtness to work, after RFA treatment of idiopathic VT
or PVCs can be demonstrated after a long-term follow up of ten
years.Conﬂict of interest
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